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ABSTRACT
Objective: Acinetobacter species is an important cause of community as well as nosocomial infections with a high mortality rate. The study was done 
to analyze the risk factors associated with Acinetobacter infections and their outcomes.
Methods: The clinical details of 100 patients having infections with Acinetobacter species over a period of 1-year were analyzed for underlying risk 
factors and outcomes. The antibiotic sensitivity results were interpreted according to the Clinical Laboratory Standards Institute guidelines.
Results: Majority of the infections caused by the Acinetobacter species were lower respiratory tract infections, most common being ventilator-
associated pneumonia. 47% of the isolates were multi drug resistant and 26% were extensively drug resistant. There is a significant chance of drug 
resistance and a poor outcome with intensive care unit (ICU) stay, prolonged hospital stay of more than 7 days, the presence of 5 or more risk factors. 
Endotracheal intubation and mechanical ventilation were the risk factors for increased drug resistance in the ICU. Drug resistance was also seen more 
frequently in patients with chronic obstructive pulmonary disease, chronic kidney disease, and patients on post-operative care.
Conclusion: The steady increase in drug resistant Acinetobacter species and limited antibiotics available advocates an uncompromising approach 
toward infection control and a judicious use of antibiotics especially in the ICU. An understanding about the risk factors helps in the appropriate 
approach and management of the patient.
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INTRODUCTION
Acinetobacter baumannii has been notified by the Infectious Disease 
Society of America as “red alert” pathogen [1]. They are opportunistic 
pathogens and cause both community acquired and health-care 
associated infections such as nosocomial pneumonia, meningitis, 
urinary tract infection, skin and soft tissue infection and bacteremia, 
with a high mortality rate [2]. With the acquisition of antibiotic 
resistance genes, there is an increase in the prevalence of multi-drug 
resistance (MDR) in Acinetobacter species [3].
This study was done to analyze the factors responsible for infections 
caused by Acinetobacter species and those associated with infection 
due to MDR Acinetobacter strains.
METHODS
This study is a prospective study conducted in intensive care units (ICUs) 
and wards of a tertiary care hospital in Mangalore, Karnataka, over a 
period of 1-year. 100 patients with infections caused by Acinetobacter 
species were analyzed for associated risk factors using the medical 
records of each patient. All outpatients and patients with colonization 
with Acinetobacter species were excluded from the study. Non-random 
sampling method was adopted for the study. The following variables were 
analyzed: ICU admission, duration of stay in the hospital, mechanical 
ventilation, endotracheal intubation, the presence of underlying diseases 
or conditions, including chronic obstructive pulmonary disease (COPD), 
diabetes mellitus, hypertension, chronic kidney disease (CKD), chronic 
liver disease, ischemic heart disease, malignancy, past history of device 
implantation or surgery, and instrumentation at various sites such as 
Central venous catheters [4-7]. Ventilator-associated pneumonia (VAP) 
is defined according to the American Thoracic Society as pneumonia 
that occurs 48-72 hrs or thereafter following endotracheal intubation, 
characterized by the presence of a new or progressive infiltrate, signs 
of systemic infection (fever, altered white blood cell count), changes in 
sputum characteristics, and detection of a causative agent [8].
The antibiotic susceptibility test results of these isolates of Acinetobacter 
species were interpreted according to Clinical Laboratory Standards 
Institute recommendations [9-11]. MDR Acinetobacter isolates were 
defined as non-susceptible to one or more agent in three or more 
antimicrobial categories. Extensively drug resistant (XDR) isolates 
were defined as non-susceptible to one or more agents in all but two 
or less antimicrobial categories, and pan-drug resistant (PDR) strains 
were defined as non-susceptible to all antimicrobial agents [12].
RESULTS
Out of the total 100 patients included in the study, 63 were males and 
37 were females. Maximum isolates (46 out of 100) were from the 
elderly population, i.e., >55 years of age, followed by 23 isolates in the 
age group 36-55 years, 16 isolates in the age group 16-35 years, 13 
isolates in the neonates and 2 in children till 15 years of age.
The majority of the infections caused by Acinetobacter species occurred 
in patients admitted in the ICUs (73%). 61% of infections in our study 
were lower respiratory tract infections (LRTIs), out of which 54.1% 
(33 out of 61) were VAP. The specimen used were endotracheal tube 
secretions (35), sputum (21), and broncho alveolar lavage (5) (Table 1). 
To diagnose LRTI or VAP, strict diagnostic criteria was used and all 
colonizers were excluded from the study.
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All the skin and soft tissue infections were post-operative cases where 
Acinetobacter species were isolated from the pus and wound swab 
specimens collected from the operated site.
About 72% of the infections caused by Acinetobacter species in the study 
were monomicrobial, while 28% were polymicrobial, most commonly 
associated with Klebsiella species (14%), followed by Pseudomonas 
species (5%), Enterococcus species (3%), Staphylococcus aureus (3%), 
Citrobacter species (2%), and Candida species (2%).
Risk factors associated with these infections caused by Acinetobacter 
species were analyzed. The most common risk factor for the 
development of infection with Acinetobacter species was intubation 
followed by mechanical ventilation and insertion of medical devices 
(Table 2). Diabetes was associated with 29 out of 100 patients.
Around 47% of these isolates were MDR while 26% of these isolates 
were XDR. There were no PDR strains.
67 % of the patients suffering from the infections caused by Acinetobacter 
species improved, while 22% of the patients expired. 7% of the patients 
worsened while in 4%, the condition remained unchanged.
The majority of patients, i.e., 83% had a prolonged duration of hospital 
stay (7 days or more). Patients with prolonged ICU stay, i.e., more 
than 7 days had increased association with infections caused by MDR 
Acinetobacter species and also a poor outcome, i.e., worsening of the 
condition or mortality (p<0.05). There was significant chance of the 
Acinetobacter species being drug resistant when five or more risk 
factors were present (p<0.05). Mortality increased significantly when 
it was associated with one or more risk factors (p<0.001). When each 
of the risk factors was analyzed to risk of mortality and drug resistance, 
it was observed that only mechanical ventilation was significantly 
associated with both of them (p<0.05). But in the ICU settings, other 
risk factors such as endotracheal intubation, mechanical ventilation, 
post-operative case, COPD and CKD were also significantly associated 
with drug resistance (p<0.05).
DISCUSSION
Acinetobacter species, once considered to be a part of the commensal 
flora of humans, now pose a serious challenge, especially in health-
care settings where it is now an important cause of life-threatening 
infections. The ability to survive for prolonged duration in the hospital 
settings and the rapid acquisition of MDR has made infections due to 
Acinetobacter species, a major concern in health-care settings.
We found increased incidence of infection in males (63%) and a 
male:female ratio of 1.7:1. LRTI due to Acinetobacter species was the 
most common infection in our study (61%). Most patients (63.9%) 
with LRTI belonged to the >55 years age group. 65.6% males had 
LRTI compared to only 34.4% of females which could be related to the 
increased history of smoking among men. Smoking damages the cilia 
in the respiratory tract and alters the structural and immune defenses 
of the host predisposing the host to infections. Advanced age is a risk 
factor for acquiring infection with Acinetobacter species which could 
be attributed to the poor immune defense mechanisms in the elderly 
age group and the presence of coexisting comorbidities and chronic 
diseases. Other studies on infections with Acinetobacter species 
also reported male preponderance and increased incidence in older 
group [6,13].
Nearly 35 (57.4%) of the isolates from LRTI were isolated from 
endotracheal tips and aspirates, 21 (34.4%) from sputum and 5 (8.2%) 
from bronchoalveolar lavage. 54.1% of these patients with LRTI had 
developed VAP. 14% of the infections were skin and soft tissue infections 
while 10% of the infections were blood stream infections. Similar results 
were obtained in the study done by Prashanth and Badrinath, in which 
they found respiratory tract infections to be the most common infection 
caused by Acinetobacter species (51.2%), followed by bloodstream 
infections (16.2%) [5]. In another study done by Lee et al., respiratory 
infections were the most common infections caused by both imipenem-
resistant and imipenem-sensitive A. baumannii isolates, 57% and 
64%, respectively [14]. The type of infections caused depends on the 
condition of the patients and the type of interventions and procedures 
performed, and thus varies from hospital to hospital. In our setup, 81% 
of the patients had endotracheal intubation and 36% of the patients 
were mechanically ventilated.
Mixed infections, combining Acinetobacter species along with other 
organisms have been found to be more virulent. These infections are 
more resistant to treatment and mortality is high in these patients 
like in studies by Telley and Roberts [15]. 28% of our patients had 
mixed infections. Most of these polymicrobial infections were from 
respiratory tract specimens (78.6%) and Klebsiella pneumoniae was 
the most common associated organism isolated from polymicrobial 
infections, followed by Pseudomonas species. In our study, 57.1% of the 
mixed infections were due to XDR Acinetobacter strains, 28.6% were 
due to MDR Acinetobacter strains. 53.6% of the mixed infections in our 
study were associated with mortality and poor outcome.
We found a strong association between ICU admission and 
development of infection with Acinetobacter species (p<0.05). The 
majority of the patients included in the study were admitted to the 
ICU (73%), which indicates that ICU admission is a predisposing 
factor for the occurrence of infections caused by Acinetobacter species. 
Similar results were found by Tripathi et al. [16], Lone et al. [6] who 
found that Acinetobacter infections in the ICU were significantly more 
common than those in the general ward. Patients in ICU are sicker 
and require more invasive monitoring and therapeutic procedures. 
The environmental contamination of the ICU and transmission of 
the infection from colonized patients is probably another important 
source of infection due to Acinetobacter species. The development of 
ICU-acquired infections is associated with worse outcomes including 
increased morbidity and mortality [17]. 75.3% (55 out of 73) of the 
patients admitted to the ICU were infected with drug-resistant strains 
of Acinetobacter species, 54.8% of the strains being XDR and 20.5% of 
the strains being MDR. The increased drug resistance seen in the ICU 
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settings is probably because of the extensive use of broad-spectrum 
antibiotics for the critically ill patients. The mortality in the ICU settings 
was 30.14%. All the 22 patients who expired were admitted in the ICU.
Risk factors like prolonged duration of stay in the hospital, intubation, 
mechanical ventilation, post-operative cases, and chronic underlying 
conditions such as diabetes mellitus, hypertension, ischemic heart 
disease, COPD, chronic liver disease, CKD, and malignancy were 
analyzed. Among these, intubation was the most common underlying 
predisposing factor present in 81% of the patients. Among the 
patients suffering from respiratory tract infections with Acinetobacter 
species, 86.9% were intubated during the course of the admission. 
All the 14 patients suffering from skin and soft tissue infections due 
to Acinetobacter species, were post-operative cases and the specimen 
was taken from the site of operation. Among the 5 patients suffering 
from urinary tract infection due to Acinetobacter species, 4 patients had 
urinary catheters inserted. Studies, conducted by Tripathi et al. [16] 
and Lone et al. [6] found that mechanical ventilation, admission to ICU, 
underlying chronic debilitating condition and a prolonged hospital 
stay were significant predisposing factors. The increased occurrence of 
infection by Acinetobacter species in patients with underlying chronic 
conditions reiterates the important opportunistic characteristic of 
Acinetobacter species, which affects compromised hosts. Prolonged 
hospital stay of more than a week also predisposes the patient to the 
hospital environment and stresses on the nosocomial character of the 
organism. 83% of the patients in our study had a prolonged hospital 
stay of more than a week. Acinetobacter strains have the ability to 
adhere to the surfaces by forming biofilm [18]. This is probably the 
reason why intubation and instrumentation like catheterization expose 
the person to infections caused by Acinetobacter species.
The occurrence of bacteremia due to Acinetobacter species in our study 
was 10%. Out of the 10 patients, 3 were secondary to an indwelling 
catheter, 2 were secondary to VAP, and 2 were secondary to a urinary 
tract infection, while in 3 patients, the source was unknown. Prashanth 
et al. in their study found the incidence of bacteremia to be 16.27% 
with the most common source being respiratory tract infection 
(65%) [5]. Intravascular catheters and respiratory tract infections 
are the most common sources of bacteremia by Acinetobacter species, 
while urinary tract infections and surgical wounds are the less common 
sources. These stress the importance of indwelling catheter care and 
infection control policies in preventing bloodstream infections due to 
Acinetobacter species. Some of the bacteremia’s with source unknown 
could be secondary to undiagnosed vascular catheter infections or have 
an intestinal origin due to bacterial translocation. This is supported by 
the demonstration that digestive tract colonization by A. baumannii is 
more frequent and advanced in ICU patients [19,20].
In our study, the mortality due to infection caused by Acinetobacter 
species was 22%. The presence of risk factors in our study was 
statistically significant to mortality. Mechanical ventilation significantly 
increased the chances of mortality. Earlier studies reported a 
mortality rate of 23% in their study, with mechanical ventilation and 
infection with drug-resistant isolates as the risk factors associated 
with mortality [5]. Ventilator-associated pneumonia due to non-
fermenting Gram-negative bacteria like Acinetobacter species is a 
known cause of increased mortality in hospitals [21]. Mortality and 
poor clinical outcomes are also due to high incidence of drug resistance 
in Acinetobacter species. This leaves the clinician with few treatment 
options and also the empiric therapy given is not effective.
Individually, among all the risk factors, mechanical ventilation was 
significantly associated with increase in drug resistance of the 
isolate. Furthermore, the presence of five or more risk factors is 
significantly associated with increase in drug resistance. Fukuta et al. 
and Surasarang et al. in their individual studies found mechanical 
ventilation, prolonged intensive unit care stay and prior antimicrobial 
use to be significant risk factors for acquisition of infection due to MDR 
Acinetobacter isolates [22,23]. Pertaining solely to the ICU settings, 
the risk factors that significantly lead to increase in drug resistance 
were found out to be mechanical ventilation, endotracheal intubation, 
post-operative cases and COPD and CKD. In addition to more severe 
health conditions of patients in ICU settings, cross-contamination, to 
a large extent, is associated with the high drug resistant rate, which 
has been demonstrated by numerous outbreaks of MDR isolates in 
critical centers [24,25]. Accordingly, to avoid the transmission of 
environmental organisms to patients from contaminated hands of 
medical staff and equipment, it is of great necessity and importance to 
reinforce the infection control strategies like hand washing and bundle 
care, especially in the ICU setting.
The Acinetobacter isolates causing infection in the ICU settings were 
significantly more resistant to antibiotics as compared to the isolates 
causing infection in the Ward settings (p<0.05). In our study, 57% of 
the Acinetobacter isolates which caused infection were carbapenem-
resistant. Intra-hospital and inter-hospital spread of MDR Acinetobacter 
species, especially carbapenem-resistant A. baumannii is becoming 
an issue of concern and leads to further spread of drug-resistant 
Acinetobacter strains, leaving no option apart from polymyxins for 
treatment [26]. Because of the same reasons, mortality was also found 
out to be significantly high in patients with infection with drug resistant 
Acinetobacter strains rather than susceptible Acinetobacter strains 
(p<0.05).
CONCLUSION
Acinetobacter species, especially A. baumannii is an important cause of 
severe nosocomial infections and hospital outbreaks; hence, this study 
of Acinetobacter species and their antibiotic susceptibility pattern 
is of immense significance. Although the resistance rates for these 
pathogens have been increasing steadily, the development of new drugs 
for these infections has not increased proportionately. Infections due to 
MDR Acinetobacter species increase the cost of treatment and severely 
affects clinical outcome and has very limited treatment options which 
include polymixins. The present scenario of escalating drug resistance 
in Acinetobacter species highlights the importance of uncompromising 
approach towards infection control, especially in the ICUs. An attempt 
to study the risk factors and the conditions that predispose a person 
to infections due to Acinetobacter species will help the treating 
physician to approach a patient and manage the infection along with 
the underlying condition appropriately.
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